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Abstract
Objective: This study has been designed and conducted to develop domestic indicators for
evaluating the performance of clinical governance in dimensions of risk management and clinical
effectiveness.
Design: This study implemented a 5-stage process including conducting a comprehensive literature
review, expert panel (∼1000 h per person per session, 11 experts), semi-structured interviews,
a 2-round Delphi study (33 experts were in attendance) and a final expert panel (8 experts were in
attendance).
Setting: East Azerbaijan-Iran Province.
Participants: Fifty-six specialists and experts in different fields of medical sciences.
Main Outcome Measures: Importance and applicability of indicators.
Results: Using a thorough literature review, 361 indicators (129 risk management indicators in 4
dimensions and 232 clinical effectiveness indicators in 18 dimensions) were found. After conducting
expert panels and interviews, the number of indicators decreased to 168 cases (65 risk management
indicators in 4 dimensions and 103 clinical effectiveness indicators in 12 dimensions). Two rounds of
Delphi identified four indicators that were omitted. The members of the final expert panel agreed on
113 indicators (43 risk management indicators in 4 dimensions and 70 clinical effectiveness indica-
tors in 11 dimensions).
Conclusion: In this study, indicators for assessing clinical governance in domains of risk manage-
ment and clinical effectiveness were designed that can be used by policy-makers and other author-
ities for improving the quality of services and evaluating the performance of clinical governance.
Those indicators can be used with slight modifications in other countries having healthcare systems
similar to that of Iran.
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Background
The quality of care delivery is an increasingly important issue in
healthcare sector throughout the world. Healthcare professionals
aim to increase patient benefits and apply many methods to improve
patient care [1, 2]. The quality of care can be defined as ‘the degree to
which health services for individuals and populations increase the like-
lihood of desired health outcomes and are consistent with current pro-
fessional knowledge’ [3]. Improving quality of healthcare requires
performance measurement and feedback [4–7]. The assessment of
the quality of care has become increasingly important to providers,
patients, regulators and purchasers [8–12].
Using performance indicators and outcomemeasures is oneway to
measure and monitor the quality of care and services. Performance in-
dicators and outcome measures allow the quality of care and services
to be measured [13–16]. Developing and reporting indicators have be-
come widely accepted methods for improving the quality in most
countries, and several studies have been conducted to design and im-
plement these indicators in healthcare systems [1, 17–22]. ‘Indicators
usually provide a quantitative (i.e. numerical) measure that can be
used as a guide to monitor and evaluate the quality of important pa-
tient and support service activities’ [23]. A literature review examining
the development and implementation of indicators shows that the
most of these studies have been conducted in high-income countries
(HICs).
In Iran and many other low- and middle-income countries, the use
of indicators in the healthcare sector has not been considered suffi-
ciently. In Iran, due to the increased pressure on the health system,
theMinistry of Health andMedical Education (MOHME) has recent-
ly implemented models and strategies to improve the quality of health-
care, such as European Foundation for Quality Management model.
Since such attempts did not make a major impact, the MOHME
decided to apply the NHS ‘clinical governance’ model with seven pil-
lars including risk management, clinical effectiveness, patient and
public involvement, clinical audit, education and training, staff and
staff management, and use of information [24, 25].
To evaluate the performance of clinical governance, specific and
appropriate indicators commensurate with the Iranian health system
context are required. This study aims to develop and select indicators
to evaluate the clinical governance model in the domains of risk man-
agement and clinical effectiveness.
Methods
After getting approval from the medical science board of Tabriz
University, a multiphase study was designed to develop and evaluate
performance indicators of the clinical governance model in hospitals
in East Azerbaijan, Iran, during 2013 and 2014. The first phase of
this study aimed to identify the appropriate indicators and included
an extensive literature review, expert panels, semi-structured inter-
views and Delphi survey [26].
Literature review
A comprehensive literature review was conducted to identify the per-
formance indicators for clinical governance, risk management and
clinical effectiveness. Through the literature review, the following da-
tabases were searched for relevant studies: PubMed, Ovid Medline,
Science Direct, Google Scholar, Medline, SID (a scientific information
database developed to index articles published in Iranian journals)
and relevant websites The keywords used included: clinical govern-
ance, indicator*, risk management*, clinical effectiveness*, hospital
performance*, quality indicator*, clinical indicator*, hospital ac-
creditation indicator*, as well as the Persian equivalents of these key-
words for the time period from 1975 to 2012. All articles and reports
published in English and Persian languages were also searched. Man-
ual searches were also conducted through the index listings and peer-
reviewed medical journals. Additional searches were conducted using
Cochrane Collaboration and Evidence-BasedMedicine, as well as clin-
ical practice guidelines, consensus reports and best practice reports.
Criteria for selecting relevant studies included indicators in hospitals
(not in primary care facilities), the provision of adequate descriptive
information about indicators, and extracted, summarized and
reported results in appropriate extraction tables.
Expert panel
In the second phase of the study, five expert panels were held to review
and adapt the indicators to the Iranian health system or hospital con-
text. The expert panels were comprised of stakeholders, project part-
ners and external experts.
Panel members were composed of the following individuals:
(i) four clinician specialists (one urologist, one infectious disease spe-
cialist, one neurologist and one emergency medicine specialist),
(ii) three nurses,
(iii) one epidemiologist,
(iv) one PhD with expertise in health services management,
(v) one director of the clinical governance department and
(vi) one expert in hospital evaluation.
Expert group members were selected according to the following
criteria:
(i) practical knowledge of risk management and/or clinical effectiveness,
(ii) knowledge and experience about performance indicators,
(iii) employed in health system and
(iv) interested in and availability to participate in the study.
The session lasted 2 h and was organized as a group discussion. Dis-
cussions were primarily carried out about the feasibility and import-
ance of collected indicators.
Interviews
In some specific domains, due to the lack of expert knowledge, inter-
views were conducted with experts in intended domains. Semi-
structured interviews were conducted with the following experts:
(i) physiotherapist for physiotherapy indicators,
(ii) epidemiologist for mortality indicators,
(iii) medical records expert (responsible for medical records and
Hospital Information System (HIS)) and
(iv) expert in hospital statistics.
The duration of the interviews varied from 30 to 90 min. Experts’
comments were applied on forms provided for modifying indicators.
Delphi survey
After conducting the expert panel and interviews, selected indicators
were entered into the Delphi survey phase. Indicators were categorized
into the following areas:
(i) risk management including indicators of patient safety, staff
safety, equipment safety and environment safety and
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(ii) clinical effectiveness including indicators of infection control,
surgery, gynecology, ICU, pediatrics, pathology, oncology, oph-
thalmology, radiology and physiotherapy (indicators of mortal-
ity and emergency medicine were not entered into the Delphi
survey phase due to the existence of the appropriate national
indicators).
The Delphi questionnaire/form was designed based on the extensive
literature review and experts’ comments. Questionnaires were sent
to experts from different medical specialties and basic sciences
(epidemiologist (n = 2), PhD in Health Services Management (n = 2),
Urologist (n = 2), community medicine specialist (n = 2), emergency
medicine specialist (n = 1), infectious disease specialist (n = 1), mental
disease specialist (n = 1), medical informatics expert (n = 1), patholo-
gist (n = 1), PhD in environmental health (n = 1), PhD in public health
(n = 2), Medical Equipment expert (n = 1), nurse (n = 2), Rehabilita-
tion specialist (n = 2), director of hospital quality improvement (n = 1)
and director of hospital infection control (n = 1)). The panelists rated
each indicator in terms of ‘importance’ and ‘applicability’. Respon-
dents indicated whether they ‘agreed’, ‘had no idea’ and ‘disagreed’.
Agree and disagree responses were also divided into a four-point
Likert-type rating scale that ranged from ‘strongly agree/disagree’ [1]
to partially agree/disagree [4] (see Supplementary Appendix 1).
After calculating the mean of responses, indicators with a mean of
equal to or less than 4 were omitted, indicators with the mean of 4 to 7
entered to the second Delphi phase and indicators with mean of great-
er than or equal to 7 were definitely accepted. To assess the validity of
the questionnaire, the Content Validity Index (CVI) and modified
KAPPAwere assessed based upon expert perspectives. A minimum cu-
mulative modified KAPPA score of 0.76 is expected to be achieved for
the content validation [27].
Final expert panel
A final expert panel was held with participants including one epidemi-
ologist, three clinician specialists (one urologist, one infectious disease
specialist one neurologist) and four nurses. This study was approved
by the ethic committee in Tabriz University of Medical Sciences. Indi-
viduals were asked to participate on a voluntary basis, and informed
consent was obtained from them. Confidentiality of the study
processes was assured.
Results
Through the literature review 361 indicators were identified. Five ex-
pert panels, four semi-structured interviews, two rounds of Delphi sur-
veys and a final expert panel were conducted while panelists examined
the indicators from aspects of ‘importance’ and ‘applicability’. Ultim-
ately, several indicators were excluded, merged, changed in order to be
well suited to Iranian hospital settings and accepted. Results of this
process are summarized in Table 1.
Through the literature review, 129 indicators were found for risk
management in four dimensions and clinical 232 indicators were
found for effectiveness in 18 dimensions. While the highest number
of indicators was related to patient safety, the lowest number of indi-
cators was associated with pediatric and radiology. Internal medicine
and hospital-wide indicators were merged into other indicators, anes-
thesia and endoscopy indicators were excluded due to the lack of
sources and home care indicators were excluded because these services
are not provided in Iranian hospitals. The members of the final expert
panel decided to exclude indicators of emergency medicine because
these indicators are currently collected by Iranian hospitals. The
main reasons for excluding other indicators are as follows:
(i) the lack of data,
(ii) weaknesses or lack of information systems such as HIS, manage-
ment information system (MIS) and the lack of medical records,
(iii) the lack of sources such as insufficient number of staff, the lack
of medical equipment and the lack of time,
(iv) not provided for intended services,
(v) the lack of cooperation from authorities and hospital personnel
for data collection
(vi) social and cultural issues
(vii) the difference between Iranian hospitals administration and
management systems and those in HICs and
(viii) different pattern of diseases.
The process of study is shown in Figure 1.
Discussion
In order to evaluate the performance of the clinical governance model
in hospitals, the use of functional indicators to determine the rate of
success and improvement is inevitable. In order to achieve greater
transparency, better accountability and improved quality of services,
functional indicators may play a key role. These indicators may be
also useful to evaluate and measure the performance and the degree
to which predetermined goals have been reached [28]. In this study,
113 indicators in domains of risk management and clinical effective-
ness, based on the socio-economic situation and also hospital settings
in Iran, were designed using different methods and stages (structured
literature review, interviews, expert panels and Delphi technique).
In previous studies, researchers [29] extracted evaluation indica-
tors of clinical governance in domains of risk management and clin-
ical effectiveness using literature review and focus group discussion
with staff working in all hospitals of East Azerbaijan province. This
study tried to design indicators of clinical governance in these two do-
mains, which finally led to the design of 204 indicators. Researchers
in the mentioned study concluded that the weakness of the informa-
tion system and the lack of preparation of hospitals have been the
main reasons for excluding several indicators. Therefore, supporting
the information systems of hospitals, the proper completion of med-
ical records and an emphasis given by hospitals’ top managers to col-
lect and use indicators could be effective in using indicators in
hospitals.
The regional office of the World Health Organization in Europe in
a project titled ‘Performance assessment tool for quality improvement
in hospitals (PATHS)’ and by using the expert panel and systematic re-
view of literature and also with the cooperation with 20 European
countries and piloted indicators in 8 countries developed 100 per-
formance indicators in 6 dimensions including clinical effectiveness,
safety, patient centeredness, staff orientation, efficiency of services
and responsive governance [30]. The number of prepared indicators
in this study is more than that of the study mentioned earlier, and
the reason could be due to the accuracy and wide investigation of
the studied domains in the latter study. While the latter study may
be useful and effective, it can also be useless in situation where there
is a lack of time. So, proper policy-making should be considered while
using indicators of this study.
One of the main domains in the dimension of risk management is
patient safety. Given the importance of this issue, a great attention has
been paid to patient safety in many studies and the development of
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Table 1 Developing indicators in dimensions of risk management and clinical effectiveness
Risk management Clinical effectiveness
Find in literature
review
After five-experts panel
and four interviews
After two-round
Delphi survey
After final experts
panel
Find in literature review After five experts panel
andfour interviews
After two-round Delphi
survey
After final experts panel
1. Patient
safety = 41
1. Patient safety = 20 1. Patient safety = 20 1. Patient
safety = 21
1. Infection control = 35 1. Infection control = 28 1. Infection control = 28 1. Infection control = 14
2. Staff safety = 39 2. Staff safety = 19 2. Staff safety = 19 2. Staff safety = 11 2. Mortality = 23 2. Mortality = 17 2. Mortality = 17 2. Mortality = 17
3. Environment
safety = 28
3. Environment
safety = 15
3. Environment
safety = 14
3. Environment
safety = 6
3. Internal medicine = 22 3. Internal medicine =M 3. Obstetric = 11 3. Obstetric = 6
4. Equipment
safety = 21
4. Equipment
safety = 11
4. Equipment
safety = 10
4. Equipment
safety = 5
4. Oral health = 19 4. Oral health = E 4. Ophthalmology = 5 4. Ophthalmology = 5
5. Hospital-Wide = 15 5. Hospital-Wide =M 5. Emergency
medicine = 5
5. Surgery = 5
6. Obstetric = 15 6. Obstetric = 11 6. Oncology = 4 6. Oncology = 2
7. Ophthalmology = 14 7. Ophthalmology = 5 7. Surgery = 7 7. ICU = 6
8. Anesthesia = 13 8. Anesthesia = E 8. ICU = 8 8. Pathology = 5
9. Emergency
medicine = 9
9. Emergency medicine = 5 9. Pathology = 5 9. Rehabilitation
medicine = 5
10. Oncology = 9 10. Oncology = 5 10. Rehabilitation
medicine = 4
10. Pediatric = 2
11. Endoscopy = 8 11. Endoscopy = E 11. Pediatric = 4 11. Radiology = 3
12. Home care = 8 12. Home care = E 12. Radiology = 3
13. Surgery = 7 13. Surgery = 7
14. ICU = 7 14. ICU = 8
15. Pathology = 6 15. Pathology = 5
16. Rehabilitation
medicine = 6
16. Rehabilitation
medicine = 5
17. Pediatric = 4 17. Pediatric = 4
18. Radiology = 4 18. Radiology = 3
Total = 129 Total = 65 Total = 63 Total = 43 Total = 232 Total = 103 Total = 101 Total = 70
M, merged; E, excluded.
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indicators of patient safety has been an ongoing issue. One of the most
important studies is the study conducted by the Agency for Healthcare
Research and Quality. This organization developed patient safety in-
dicators in a study published in 2007 and introduced 20 indicators as
the main and vital indicators for evaluating patient safety in healthcare
centers [31]. Another important study in this field is the study con-
ducted by the Organization for Economic Cooperation and Develop-
ment in 2004 in which 21 indicators of patient safety in 5 major
domains including nosocomial infections, surgical and post-surgical
complications, sensitive and important events, obstetric indicators
and other indicators of unwanted events related to patient safety
were extracted and developed [32]. Conducting several studies in the
domain of patient safety and great investments in conducting these
studies indicate the importance of patient safety and the role of indi-
cators in its improvement. Therefore, using local patient safety indica-
tors developed in this study could be used for improving patient safety
in Iranian hospitals and, with a slight modification, could be used in
hospitals in countries similar to Iran.
In the dimension of clinical effectiveness, the infection control
indicators have been considered as important indicators in this
study. In the field of infection control, several studies have been con-
ducted on infection control indicators [33–36]. In one of the most im-
portant studies, conducted by Blais et al. (2009) [37] in Canada, the
authors introduced 97 key indicators in 22 domains of infection con-
trol using a literature review, expert panel, management consulting
and data collection from 6 hospitals. The Australian Council on
Healthcare Standards [38] and the Joint Commission on Accreditation
of Healthcare Organizations [39] also designed and used indicators of
infection control. Considering complications and unwanted conse-
quences of hospital infections and the effect of using indicators on
the control and decrease these consequences, using indicators identi-
fied in the current study and indicators available in references may
be effective in this area.
A five-stage process including conducting a comprehensive litera-
ture review, expert panels, interviews, Delphi technique and a final ex-
pert panel was used in this study. By investigating those studies on
developing indicators, it can be concluded that similar processes
have been used to develop indicators [1, 11, 40]. In this study, after
a literature review and the expert panels were conducted, key infor-
mants were interviewed. The indicators obtained from the literature
review were modified and improved. So, there were few problems in
the Delphi stage. As it has been mentioned in the results section of
the Delphi phase, only 4 indicators out of the total of 168 indicators
had low scores and were omitted from the study. Therefore, the pro-
cess used in this study can be used as a pattern for developing indica-
tors in further studies.
Figure 1 Flowchart of the study process
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One of the weaknesses of the current study is the exclusion of some
domains (such as home care and endoscopy). These domains were ex-
cluded from the study due to the lack of sufficient provision of these
services in Iranian hospitals, the lack of adequate information and the
lack of required equipment in this field. Furthermore, there was the
risk of bias in this study, because members might select certain indica-
tors for inclusion during the panel sessions. However, such bias would
be minimized because of the multidisciplinary nature of the panel
(i.e. the participation of a diverse range of participants including
healthcare providers such as doctors and nurses, health policy makers
and methodologists). During the panel sessions, the panel members
were allowed to freely suggest, discuss and add further quality mea-
sures to the initial list.
Conclusion
Since clinical governance (7-columnmodel) has been implemented for
the first time in Iranian hospitals and also given that this model has
been firstly designed in NHS of England (which is very different
from Iranian healthcare system), reliable and valid local indicators
are required in order to assess this model. In this study, using various
processes and ideas of specialists and experts in different fields of med-
ical sciences, local indicators for assessing clinical governance model
in domains of risk management and clinical effectiveness were
designed that can be used by policy makers, managers and other au-
thorities for improving the quality of services and evaluating the per-
formance of clinical governance model in Iranian hospitals. The
results of this study can be used with slight modifications in other
countries having healthcare systems similar to that of Iran.
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